Impact of biostimulants based amino acids and irrigation frequency on agro-physiological characteristics and productivity of broccoli plants

Abstract scientists are concerned about the utilizing of biostimulants-based amino acids in plant feeding and mitigating negative effects of water stress. As a result, two-year field experiments were conducted at Faculty of Agriculture's experimental station at Cairo University to study the effectiveness of liquid yeast waste (CMS) and Cargo amino acids (AAs) on the agro-physiological features of broccoli plants with different irrigation frequencies (every 5, 10, and 15 days). Compared with control plants, the foliar application of AAs and CMS significantly increased plant height, photosynthesis pigments, head weight, head diameter, head height, plant yield, and quality at different irrigation frequencies. Likewise, both treatments (CMS and AAs) significantly improved ascorbic acids by 16.65% and 15.95% and increased total phenol content by 24.10% and 36.60%, respectively, compared to control plants. Accordingly, the highest productivity was achieved for broccoli grown under irrigation every five days with the CMS bio-stimulant, where it was 3111.17 kg ha-1, while the lowest productivity was achieved for the control treatment in which no biostimulants were added and irrigation frequency every 15 days, and the productivity was 1376.22 kg ha-1. Plants irrigated every 15 days produced the highest levels of abscisic acid (ABA) and superoxide dismutase (SOD), followed by plants irrigated every 10 days and every 5 days. Exogenous application of amino acids bio-stimulants could be suggested to improve vegetative growth, biochemical characteristics, productivity, and nutritional value as well as to mitigate negative effects of water scarcity.

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century